S. Gail Eckhardt, MD is a tenured Professor and Head of the Division of Medical Oncology at the University of Colorado at Denver and Health Sciences Center, where she also holds the Stapp/Harlow Endowed Chair for Cancer Research and is the Senior Associate Director for Translational and Collaborative Research at the University of Colorado Comprehensive Cancer Center.

Dr Eckhardt is a member of ESMO and has served on the Translational Research Working Group since 2009. Dr Eckhardt has also served on numerous committees/study sections, including the ASCO Molecular Oncology Task Force, the ASCO Board of Directors, the FDA Oncology Drugs Advisory Committee, the NCI Developmental Therapeutics Study Section, and the NCI Cancer Centers Study Section. She is also a member of the NCI Colon Cancer Task Force. In addition, Dr Eckhardt has been an Associate Editor of Clinical Cancer Research, Journal of Clinical Oncology, and Investigational New Drugs.

Dr Eckhardt is the Principal Investigator on grants involving early clinical trials and colorectal cancer research and has conducted numerous phase I and II clinical trials. She has published over 135 manuscripts and serves on numerous advisory boards. Her area of interest is in the preclinical and clinical development of combinations of molecularly targeted compounds, with a laboratory focus on colorectal cancer and melanoma.